Venus Remedies informs about press release

01 Jun 2023 Evaluate

Venus Remedies has informed that it enclosed press release being issued by the Company today titled ‘Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel’.

The above information is a part of company’s filings submitted to BSE.


Venus Remedies Share Price

760.00 -25.35 (-3.23%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×